4/18
04:05 pm
gh
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
Medium
Report
Guardant Health to Report First Quarter 2024 Financial Results on May 9, 2024
4/15
11:05 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $32.00 to $28.00. They now have a "buy" rating on the stock.
Medium
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $32.00 to $28.00. They now have a "buy" rating on the stock.
4/5
10:25 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its "neutral" rating re-affirmed by analysts at Guggenheim.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its "neutral" rating re-affirmed by analysts at Guggenheim.
4/4
04:04 pm
gh
Plug and Play Welcomes First Silicon Valley Startup Batches of 2024 [Yahoo! Finance]
Medium
Report
Plug and Play Welcomes First Silicon Valley Startup Batches of 2024 [Yahoo! Finance]
4/3
08:24 am
gh
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting [Yahoo! Finance]
Medium
Report
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting [Yahoo! Finance]
4/3
08:05 am
gh
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
Medium
Report
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting
4/2
10:14 am
gh
Plug and Play Alberta Announces 72 Startups for Their Fifth Alberta Cohort [Yahoo! Finance]
Low
Report
Plug and Play Alberta Announces 72 Startups for Their Fifth Alberta Cohort [Yahoo! Finance]
3/21
05:50 pm
gh
Smart/Artificial Intelligence for In-Vitro Diagnostics Research Report 2024: Will it Replace the Physician? [Yahoo! Finance]
Low
Report
Smart/Artificial Intelligence for In-Vitro Diagnostics Research Report 2024: Will it Replace the Physician? [Yahoo! Finance]
3/18
07:06 am
gh
Unlocking Disease Prevention: Lessons From The $1,000 Genome [Forbes]
Low
Report
Unlocking Disease Prevention: Lessons From The $1,000 Genome [Forbes]
3/18
04:53 am
gh
Europe Laboratory Developed Tests Market Analysis Report 2024-2030: Rising Cancer Cases Fuel Demand, Advancements in Molecular Diagnostics Propels Expansion [Yahoo! Finance]
Low
Report
Europe Laboratory Developed Tests Market Analysis Report 2024-2030: Rising Cancer Cases Fuel Demand, Advancements in Molecular Diagnostics Propels Expansion [Yahoo! Finance]
3/15
10:10 am
gh
Blood test shows 83% accuracy for detecting colorectal cancer, study finds [CBS News]
Medium
Report
Blood test shows 83% accuracy for detecting colorectal cancer, study finds [CBS News]
3/14
02:52 pm
gh
Blood test shows 83% accuracy for detecting colorectal cancer, study finds [CBS News]
Low
Report
Blood test shows 83% accuracy for detecting colorectal cancer, study finds [CBS News]
3/13
05:13 pm
gh
A blood test for colon cancer performed well in a study, expanding options for screening [Yahoo! Finance]
Medium
Report
A blood test for colon cancer performed well in a study, expanding options for screening [Yahoo! Finance]
3/13
05:09 pm
gh
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine [Yahoo! Finance]
Low
Report
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine [Yahoo! Finance]
3/13
05:00 pm
gh
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
Low
Report
Guardant Health ECLIPSE Study Data Demonstrating Efficacy of Shield Blood-based Test for Colorectal Cancer Screening to be Published in The New England Journal of Medicine
3/12
12:11 pm
gh
Sollis Health Partners with Prenuvo to Introduce a Groundbreaking Preventative Health Model to Concierge Medicine [Yahoo! Finance]
Low
Report
Sollis Health Partners with Prenuvo to Introduce a Groundbreaking Preventative Health Model to Concierge Medicine [Yahoo! Finance]
3/5
11:45 am
gh
Metaplane Announces $13.8M Series A led by Felicis on Heels of Rapid Growth [Yahoo! Finance]
Low
Report
Metaplane Announces $13.8M Series A led by Felicis on Heels of Rapid Growth [Yahoo! Finance]
3/1
05:37 am
gh
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap [Yahoo! Finance]
Low
Report
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap [Yahoo! Finance]
3/1
05:30 am
gh
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
Low
Report
New Survey: Patients and Physicians Overwhelmingly Agree Blood Tests Could Help Close the Colorectal Cancer Screening Gap
2/28
09:33 am
gh
Litify Announces Record Performance In 2023 [Yahoo! Finance]
Neutral
Report
Litify Announces Record Performance In 2023 [Yahoo! Finance]
2/26
10:12 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Piper Sandler from $40.00 to $30.00. They now have an "overweight" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Piper Sandler from $40.00 to $30.00. They now have an "overweight" rating on the stock.
2/23
03:36 pm
gh
Guardant Health hits 52-week low after in-line guidance [Seeking Alpha]
Low
Report
Guardant Health hits 52-week low after in-line guidance [Seeking Alpha]
2/23
01:08 pm
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at JPMorgan Chase & Co. from $60.00 to $45.00. They now have an "overweight" rating on the stock.
Low
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at JPMorgan Chase & Co. from $60.00 to $45.00. They now have an "overweight" rating on the stock.
2/23
11:55 am
gh
Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Guardant Health, Inc. (NASDAQ:GH) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
2/23
10:12 am
gh
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $50.00 to $45.00. They now have a "buy" rating on the stock.
Medium
Report
Guardant Health, Inc. (NASDAQ: GH) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $50.00 to $45.00. They now have a "buy" rating on the stock.